About Yuan (Eliza) Sun
Form D filings for ADARx Pharmaceuticals from 2021 to 2023 list Yuan (Eliza) Sun as director.
Yuan (Eliza) Sun first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Yuan (Eliza) Sun in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Yuan (Eliza) Sun works with at each company, as listed on that company's latest Form D.
ADARx Pharmaceuticals, Inc. · Form D, Aug 10, 2023
RZ
Rui Zhu
Executive officer
SG
Simeon George
Director
JL
Judith Li
Director
Erez Chimovits
Director
SG
Sheila Gujrathi
Director
ZL
Zhen Li
President and Chief Executive Officer, director
CY
Chen Yu
Director
RS
Ricky Sun
Director
LK
Lorence Kim
Director
CG
Carl Gordon
Director